Wealth Enhancement Advisory Services’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
Wealth Enhancement Advisory Services's LMAT Position: Q3 2026 in Review
Wealth Enhancement Advisory Services increased its LeMaitre Vascular (LMAT) stake by 24% in Q3 2026, buying an estimated $76.3K and bringing the position to 4,449 shares worth $354K. The position accounts for ﹤0.01% of the portfolio, ranked #3179.
Wealth Enhancement Advisory Services first reported a position in LMAT in Q3 2023 and has held it in 13 quarters since. The position peaked at $442K in Q3 2024. 191 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.
- Wealth Enhancement Advisory Services held 4,449 shares of LeMaitre Vascular worth $354K as of Q3 2026.
- Wealth Enhancement Advisory Services bought 862 LeMaitre Vascular shares in Q3 2026, an estimated $76.3K.
- LeMaitre Vascular made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #3179 holding.
- Wealth Enhancement Advisory Services first reported a position in LeMaitre Vascular in Q3 2023 and has held it in 13 quarters since.
- Wealth Enhancement Advisory Services's LeMaitre Vascular position peaked at $442K in Q3 2024.
- 191 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.